<DOC>
	<DOC>NCT01753180</DOC>
	<brief_summary>A prospective, multi-center, double blind, 2 stage, placebo-controlled, phase II study, evaluating acute intra-coronary injected collagenase prior to routine standard-of-care percutaneous revascularization procedures in subjects with chronic total coronary artery occlusions (CTOs).</brief_summary>
	<brief_title>Total Occlusion Study in Coronary Arteries - 5</brief_title>
	<detailed_description />
	<criteria>Male or females patients &gt; 18 years of age who has a clinically driven, planned PCI of the target CTO, in a major epicardial coronary artery, without planned revascularization of other coronary stenosis/stenoses in major epicardial segments. Target CTO must be greater than or equal to 3 calendar months prior to Screening Target CTO must meet protocol defined criteria for entry Patient is receiving a course of optimal antiischemic medical therapy (at least 2 antianginal agents or the maximum tolerated antianginal therapy) Documented chest radiation exposure &gt; 4.0 Gray within 8 weeks of Day 0 Target vessel is not an occluded stent, saphenous vein graft Patient had ACS &lt; 4 weeks from Screening, attributable to any coronary vessel Patient has nonhealed dissection plane extending to a point adjacent to the coronary lumen distal to the target CTO Patient has a known or suspected target vessel perforation within 30 days of Day 0 Angiographic exclusion criteria as defined in the protocol</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>100 Years</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>CTO</keyword>
	<keyword>PCI</keyword>
	<keyword>Angioplasty</keyword>
</DOC>